Netherlands EU Presidency holds expert meeting on faster access to innovative medicines
Wednesday 02 March 2016
The Netherlands EU Presidency recently gathered over 100 experts from across Europe at a conference in Amsterdam on 2 March, at the invitation of the Minister of Health, Welfare and Sport, Edith Schippers, to discuss new market authorisation and reimbursement procedures for innovative medicines.
During the Presidency, Ms Schippers would like to speed up market authorisation procedures for new medicines:
“Here in Europe we need to look at how we can get these medicines to patients who’ve been waiting for them as soon as possible, without any safety risks,” said the minister. “This must go hand in hand with affordability. After all, what’s the point of authorising a medicine if it’s completely unaffordable? Innovative medicines require effective collaboration on market authorisation and reimbursement policies at an early stage. At present, there is insufficient cooperation between the authorities responsible for these at both national and international level.”
The findings of the conference will be addressed at the health council meeting in April, when health ministers from the 28 EU member states will discuss the EU’s policy on medicines.